Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long‐Term Effects on Serum Immunoglobulins

OBJECTIVE: B cell–depletion therapy based on rituximab is a therapeutic option for refractory disease in patients with systemic lupus erythematosus (SLE). The aim of this observational study was to document long‐term effects on B cell function by following serum immunoglobulin levels in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Venkat, Martinez, Lina, Isenberg, David A., Leandro, Maria J., Cambridge, Geraldine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Systemic Lupus Erythematosus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485064/
https://www.ncbi.nlm.nih.gov/pubmed/27428176
http://dx.doi.org/10.1002/acr.22993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485064/
https://www.ncbi.nlm.nih.gov/pubmed/27428176
http://dx.doi.org/10.1002/acr.22993

Ejemplares similares